Biostar Pharmaceuticals Inc  

(Public, NASDAQ:BSPM)   Watch this stock  
Find more results for BSPM
+0.04 (3.54%)
May 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.10 - 1.23
52 week 0.91 - 2.27
Open 1.13
Vol / Avg. 257,067.00/271,719.00
Mkt cap 18.43M
P/E 3.86
Div/yield     -
EPS 0.30
Shares 15.48M
Beta 2.52
Inst. own 4%
May 15, 2015
Q1 2015 Biostar Pharmaceuticals Inc Earnings Release
Apr 15, 2015
Full Year 2014 Biostar Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -2.32% 7.89%
Operating margin -12.88% -2.14%
EBITD margin - 4.50%
Return on average assets -0.79% 6.52%
Return on average equity -0.89% 7.18%
Employees 438 -
CDP Score - -


NO. 588 Shijixilu
XIANYANG, 712099
+86-29-33686638 (Phone)
+86-29-33685386 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Biostar Pharmaceuticals, Inc. (Biostar) is a China-based holding company. The Company, through its wholly owned subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar) and its variable interest entity (VIE) Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical), develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the People’s Republic of China. The Company's product is the Xin Ao Xing Oleanolic Acid Capsule, an over-the- counter (OTC) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. Its product line also includes five other OTC products, 10 prescription-based pharmaceuticals, six nutriceuticals or health products and one medical device. The Company completed the acquisition of Shaanxi Weinan Huaren Pharmaceuticals, Ltd (Shaanxi Weinan). The Company's products are sold in over 27 provinces in the People’s Republic of China through 68 distributors.

Officers and directors

Ronghua Wang Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Qinghua Liu Interim Chief Financial Officer, Director
Age: 47
Bio & Compensation  - Reuters
Zhenghong Wang Chief Operating Officer
Age: 34
Bio & Compensation  - Reuters
Shuang Gong Secretary of Board
Age: 47
Bio & Compensation  - Reuters
Leung King-Fai Independent Director
Age: 41
Bio & Compensation  - Reuters
Zhongyang Shang Independent Director
Age: 63
Bio & Compensation  - Reuters
Haipeng Wu Independent Director
Age: 57
Bio & Compensation  - Reuters